Acanthamoeba species from a post-covid patient with CSF rhinorrhea; a next possible post covid menace? A case report

A case of Acanthamoeba rhinorrhea in a 32 years female, who was recently recovered from COVID-19 infectionat a tertiary care institute in India. Though, there was no standard treatment protocol for management of amoebic-meningo encephalitis. The patient was managed successfully with combination ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Keche, Archana, Chakravarty, Sharmistha, Khatoon, Shagufta, Kannauje, Pankaj, Arora, Ripu Daman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Indian Association of Medical Microbiologists. Published by Elsevier B.V. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561446/
https://www.ncbi.nlm.nih.gov/pubmed/36244850
http://dx.doi.org/10.1016/j.ijmmb.2022.09.014
Descripción
Sumario:A case of Acanthamoeba rhinorrhea in a 32 years female, who was recently recovered from COVID-19 infectionat a tertiary care institute in India. Though, there was no standard treatment protocol for management of amoebic-meningo encephalitis. The patient was managed successfully with combination therapy of amphotericin B and miltefosine. Agents having trophicidal and cysticidal activities are used for treatment of CNS Acanthamoeba infection. COVID 19 infection, steroid therapy anddiabetes mellitus which lead to low immunitywere found to be associated contributing factors.

Ejemplares similares